ad image

Allogeneic

1 / 1
From Research to Clinical Trials to Commercialization: Advancing CGT with Frozen Cellular Starting Materials
Cell Therapy

From Research to Clinical Trials to Commercialization: Advancing CGT with Frozen Cellular Starting Materials

Dominic Mancini

OrganaBio

PAO-01-25-CL-13Jan 28, 2025
Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement
Allogeneic Cell Therapy Logistics

Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement

Joy Aho, Ph.D.

Be The Match BioTherapies

PAO-06-23-CL-06Jun 27, 2023
Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles
Cell Therapy

Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-01-23-NI-01Jan 31, 2023
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
Cell Therapy

Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells

Bryan Kobel

TC Biopharm

PAO-07-022-CL-03Aug 09, 2022
Expanding Access to Cell Therapies with a Patient-Centric Focus
Cell Therapy

Expanding Access to Cell Therapies with a Patient-Centric Focus

Amy L. Ronneberg

Be The Match BioTherapies

PAO-02-022-CL-12Mar 12, 2022
Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
Cell Therapy

Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure

Chris McClain

Be The Match BioTherapies

PAO-09-21-CL-04Sep 09, 2021
Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology
Cell Therapy

Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology

Catalent

PAO-12-20-CL-01Dec 16, 2020
1 / 1